Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
135.63%
-
Total 13F principal
-
$457,074,378
-
Principal change
-
+$8,027,969
-
Total reported market value
-
$618,807,068
-
Number of holders
-
49
-
Value change
-
+$7,333,224
-
Number of buys
-
21
-
Number of sells
-
25
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q3 2015
As of 30 Sep 2015,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
49 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$457,074,378
in principal (par value) of the bond.
The largest 10 bondholders included
ZAZOVE ASSOCIATES LLC, Allianz Asset Management AG, MACKAY SHIELDS LLC, BNP PARIBAS ARBITRAGE, SA, AXA, PRUDENTIAL PLC, GOLDMAN SACHS GROUP INC, WELLS FARGO & COMPANY/MN, VICTORY CAPITAL MANAGEMENT INC, and THRIVENT FINANCIAL FOR LUTHERANS.
This page lists
50
institutional bondholders reporting positions
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.